Logo image of ALS.CA

ALTIUS MINERALS CORPORATION (ALS.CA) Stock Fundamental Analysis

Canada - TSX:ALS - CA0209361009 - Common Stock

30.98 CAD
-0.26 (-0.83%)
Last: 9/17/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALS. ALS was compared to 807 industry peers in the Metals & Mining industry. ALS scores excellent on profitability, but there are some minor concerns on its financial health. ALS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ALS was profitable.
ALS had a positive operating cash flow in the past year.
Of the past 5 years ALS 4 years were profitable.
In the past 5 years ALS always reported a positive cash flow from operatings.
ALS.CA Yearly Net Income VS EBIT VS OCF VS FCFALS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

ALS has a Return On Assets of 13.83%. This is amongst the best in the industry. ALS outperforms 95.42% of its industry peers.
Looking at the Return On Equity, with a value of 17.37%, ALS belongs to the top of the industry, outperforming 94.18% of the companies in the same industry.
The Return On Invested Capital of ALS (1.84%) is better than 89.34% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALS is significantly below the industry average of 11.74%.
Industry RankSector Rank
ROA 13.83%
ROE 17.37%
ROIC 1.84%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ALS.CA Yearly ROA, ROE, ROICALS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 210.11%, ALS belongs to the top of the industry, outperforming 99.13% of the companies in the same industry.
In the last couple of years the Profit Margin of ALS has grown nicely.
ALS has a better Operating Margin (41.65%) than 97.52% of its industry peers.
ALS's Operating Margin has been stable in the last couple of years.
ALS has a better Gross Margin (88.04%) than 99.63% of its industry peers.
In the last couple of years the Gross Margin of ALS has remained more or less at the same level.
Industry RankSector Rank
OM 41.65%
PM (TTM) 210.11%
GM 88.04%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
ALS.CA Yearly Profit, Operating, Gross MarginsALS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALS is destroying value.
ALS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ALS has been increased compared to 5 years ago.
ALS has a worse debt/assets ratio than last year.
ALS.CA Yearly Shares OutstandingALS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALS.CA Yearly Total Debt VS Total AssetsALS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALS has an Altman-Z score of 6.25. This indicates that ALS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 6.25, ALS is doing good in the industry, outperforming 65.18% of the companies in the same industry.
ALS has a debt to FCF ratio of 5.08. This is a neutral value as ALS would need 5.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.08, ALS belongs to the top of the industry, outperforming 91.08% of the companies in the same industry.
ALS has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
ALS's Debt to Equity ratio of 0.16 is on the low side compared to the rest of the industry. ALS is outperformed by 66.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 5.08
Altman-Z 6.25
ROIC/WACC0.21
WACC8.91%
ALS.CA Yearly LT Debt VS Equity VS FCFALS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

ALS has a Current Ratio of 2.35. This indicates that ALS is financially healthy and has no problem in meeting its short term obligations.
ALS has a Current ratio of 2.35. This is comparable to the rest of the industry: ALS outperforms 57.50% of its industry peers.
A Quick Ratio of 2.35 indicates that ALS has no problem at all paying its short term obligations.
ALS has a Quick ratio of 2.35. This is comparable to the rest of the industry: ALS outperforms 59.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
ALS.CA Yearly Current Assets VS Current LiabilitesALS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

3

3. Growth

3.1 Past

ALS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.63%.
The earnings per share for ALS have been decreasing by -13.58% on average. This is quite bad
ALS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.35%.
ALS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.01% yearly.
EPS 1Y (TTM)-29.63%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-24.35%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-49.66%

3.2 Future

ALS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.80% yearly.
ALS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.95% yearly.
EPS Next Y2.25%
EPS Next 2Y30.77%
EPS Next 3Y32.08%
EPS Next 5Y24.8%
Revenue Next Year-14.54%
Revenue Next 2Y1.71%
Revenue Next 3Y1.28%
Revenue Next 5Y7.95%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALS.CA Yearly Revenue VS EstimatesALS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
ALS.CA Yearly EPS VS EstimatesALS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

ALS is valuated quite expensively with a Price/Earnings ratio of 163.05.
ALS's Price/Earnings ratio is rather cheap when compared to the industry. ALS is cheaper than 86.00% of the companies in the same industry.
ALS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 67.10, which means the current valuation is very expensive for ALS.
ALS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALS is cheaper than 86.62% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, ALS is valued quite expensively.
Industry RankSector Rank
PE 163.05
Fwd PE 67.1
ALS.CA Price Earnings VS Forward Price EarningsALS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALS is valued cheaply inside the industry as 88.35% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ALS is valued cheaply inside the industry as 90.95% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 71.9
EV/EBITDA 60.3
ALS.CA Per share dataALS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ALS has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ALS's earnings are expected to grow with 32.08% in the coming years.
PEG (NY)72.61
PEG (5Y)N/A
EPS Next 2Y30.77%
EPS Next 3Y32.08%

6

5. Dividend

5.1 Amount

ALS has a Yearly Dividend Yield of 1.31%.
Compared to an average industry Dividend Yield of 13.98, ALS pays a better dividend. On top of this ALS pays more dividend than 97.03% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, ALS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

The dividend of ALS has a limited annual growth rate of 0.59%.
ALS has been paying a dividend for at least 10 years, so it has a reliable track record.
ALS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.59%
Div Incr Years4
Div Non Decr Years4
ALS.CA Yearly Dividends per shareALS.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

15.18% of the earnings are spent on dividend by ALS. This is a low number and sustainable payout ratio.
ALS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP15.18%
EPS Next 2Y30.77%
EPS Next 3Y32.08%
ALS.CA Yearly Income VS Free CF VS DividendALS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
ALS.CA Dividend Payout.ALS.CA Dividend Payout, showing the Payout Ratio.ALS.CA Dividend Payout.PayoutRetained Earnings

ALTIUS MINERALS CORPORATION

TSX:ALS (9/17/2025, 7:00:00 PM)

30.98

-0.26 (-0.83%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners19.64%
Inst Owner ChangeN/A
Ins Owners5.35%
Ins Owner ChangeN/A
Market Cap1.43B
Analysts78.18
Price Target36.43 (17.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.32
Dividend Growth(5Y)0.59%
DP15.18%
Div Incr Years4
Div Non Decr Years4
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.51%
Min EPS beat(2)-29.28%
Max EPS beat(2)-25.74%
EPS beat(4)1
Avg EPS beat(4)-16.37%
Min EPS beat(4)-29.28%
Max EPS beat(4)18.81%
EPS beat(8)2
Avg EPS beat(8)-16.05%
EPS beat(12)2
Avg EPS beat(12)-23.29%
EPS beat(16)3
Avg EPS beat(16)-14.98%
Revenue beat(2)0
Avg Revenue beat(2)-14.07%
Min Revenue beat(2)-22.8%
Max Revenue beat(2)-5.33%
Revenue beat(4)0
Avg Revenue beat(4)-13.87%
Min Revenue beat(4)-22.8%
Max Revenue beat(4)-5.33%
Revenue beat(8)2
Avg Revenue beat(8)-10.26%
Revenue beat(12)3
Avg Revenue beat(12)-7.39%
Revenue beat(16)5
Avg Revenue beat(16)-5.31%
PT rev (1m)0.4%
PT rev (3m)6.61%
EPS NQ rev (1m)-3.92%
EPS NQ rev (3m)-22.22%
EPS NY rev (1m)-11.83%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)-1.97%
Revenue NQ rev (3m)-17.22%
Revenue NY rev (1m)-4.98%
Revenue NY rev (3m)-9.01%
Valuation
Industry RankSector Rank
PE 163.05
Fwd PE 67.1
P/S 30.37
P/FCF 71.9
P/OCF 64.92
P/B 2.51
P/tB 2.51
EV/EBITDA 60.3
EPS(TTM)0.19
EY0.61%
EPS(NY)0.46
Fwd EY1.49%
FCF(TTM)0.43
FCFY1.39%
OCF(TTM)0.48
OCFY1.54%
SpS1.02
BVpS12.34
TBVpS12.34
PEG (NY)72.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.83%
ROE 17.37%
ROCE 2.78%
ROIC 1.84%
ROICexc 1.87%
ROICexgc 1.87%
OM 41.65%
PM (TTM) 210.11%
GM 88.04%
FCFM 42.24%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ROICexc(3y)3.89%
ROICexc(5y)3.81%
ROICexgc(3y)3.89%
ROICexgc(5y)3.82%
ROCE(3y)5.26%
ROCE(5y)5.17%
ROICexcg growth 3Y-14.71%
ROICexcg growth 5Y-5.44%
ROICexc growth 3Y-14.71%
ROICexc growth 5Y-5.14%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 5.08
Debt/EBITDA 3.69
Cap/Depr 38.31%
Cap/Sales 4.54%
Interest Coverage 2.43
Cash Conversion 87.43%
Profit Quality 20.1%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 6.25
F-Score5
WACC8.91%
ROIC/WACC0.21
Cap/Depr(3y)21.45%
Cap/Depr(5y)17.13%
Cap/Sales(3y)3.12%
Cap/Sales(5y)3.13%
Profit Quality(3y)194.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.63%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-66.67%
EPS Next Y2.25%
EPS Next 2Y30.77%
EPS Next 3Y32.08%
EPS Next 5Y24.8%
Revenue 1Y (TTM)-24.35%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-49.66%
Revenue Next Year-14.54%
Revenue Next 2Y1.71%
Revenue Next 3Y1.28%
Revenue Next 5Y7.95%
EBIT growth 1Y-34.28%
EBIT growth 3Y-10.93%
EBIT growth 5Y0.32%
EBIT Next Year55.21%
EBIT Next 3Y28.31%
EBIT Next 5Y19.11%
FCF growth 1Y-67.12%
FCF growth 3Y-18.25%
FCF growth 5Y17.22%
OCF growth 1Y-64.63%
OCF growth 3Y-16.08%
OCF growth 5Y0.4%